DRIVE
Dead / Cancelled — Cancelled — Section 8 (as of 28 May 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87116365
- Registration number
- 5336382
- Mark type
- Stylized text
- Filed
- 26 Jul 2016
- Published for opposition
- 27 Dec 2016
- Registered
- 14 Nov 2017
Goods and services
- Class 044 — Medical, beauty and agricultural services: Providing a registry of patients for whom the antibiotic dalbavancin has been prescribed which is used for gathering medical-related real world safety, effectiveness, and usage data; none of the above relating to or in the field of cancer treatment, cancer research, genomic research or gene sequencing
Owner
- Durata Therapeutics Holding C.V., Grand Cayman, NL
- Durata Therapeutics Holding C.V., Grand Cayman, NL
- Durata Therapeutics Holding C.V., Grand Cayman, NL
Prosecution history
- 28 May 2024 — CANCELLED SEC. 8 (6-YR)
- 14 Nov 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 14 Nov 2017 — REGISTERED-PRINCIPAL REGISTER
- 13 Oct 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Oct 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Oct 2017 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Oct 2017 — NON-FINAL ACTION E-MAILED
- 05 Oct 2017 — SU - NON-FINAL ACTION - WRITTEN
- 11 Sept 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Sept 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Sept 2017 — ASSIGNED TO LIE
- 29 Aug 2017 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Aug 2017 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 25 Aug 2017 — NON-FINAL ACTION E-MAILED
- 25 Aug 2017 — SU - NON-FINAL ACTION - WRITTEN